New pivotal trial data support effectiveness of nipocalimab for gMG
Treatment with nipocalimab in gMG patients led to significant reductions in disease severity, per top-line data from a pivotal Phase 3 trial.| Myasthenia Gravis News
Treatment with nipocalimab in gMG patients led to significant reductions in disease severity, per top-line data from a pivotal Phase 3 trial.| Myasthenia Gravis News
COVID Q & A Naturally Speaking’s blog series on COVID-19: scientifically-informed, data-driven answers to your burning questions about the coronavirus pandemic Severity of Infection with …| Naturally Speaking
A photo-detection method can measure lactoferrin in dry eye disease patients' tears, making it a possible biomarker of disease severity.| Sjogren's Syndrome News
